but the pps is going much lower. Only thing can save share price is a big spike in script #s, which have been an unmitigated disaster thus far.
There's an overhanging cloud that SNY might abandon Afrezza now too.
Once again, a completely delusional post w no understanding of the valuation of the enterprise.
U mean a "solid catalyst" like FDA approval or announcement of a partner?
How did those "solid catalysts" work out?
yes, they have lines on tues, wed, and thurs gms up